Home > National Drug Code (NDC) > Aspergillus repens

Aspergillus repens - 49288-0621-1 - (Aspergillus repens)

Alphabetical Index


Drug Information of Aspergillus repens

Product NDC: 49288-0621
Proprietary Name: Aspergillus repens
Non Proprietary Name: Aspergillus repens
Active Ingredient(s): .05    g/mL & nbsp;   Aspergillus repens
Administration Route(s): INTRADERMAL; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Aspergillus repens

Product NDC: 49288-0621
Labeler Name: Antigen Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA102223
Marketing Category: BLA
Start Marketing Date: 19740323

Package Information of Aspergillus repens

Package NDC: 49288-0621-1
Package Description: 2 mL in 1 VIAL, MULTI-DOSE (49288-0621-1)

NDC Information of Aspergillus repens

NDC Code 49288-0621-1
Proprietary Name Aspergillus repens
Package Description 2 mL in 1 VIAL, MULTI-DOSE (49288-0621-1)
Product NDC 49288-0621
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Aspergillus repens
Dosage Form Name INJECTION, SOLUTION
Route Name INTRADERMAL; SUBCUTANEOUS
Start Marketing Date 19740323
Marketing Category Name BLA
Labeler Name Antigen Laboratories, Inc.
Substance Name ASPERGILLUS REPENS
Strength Number .05
Strength Unit g/mL
Pharmaceutical Classes Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient]

Complete Information of Aspergillus repens


General Information